TotalMarketCap

Ptc Therapeutics

PTCTNasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$5.477 B

$65.56 -4.94%

Close of 6 Nov 2026

As of 6 Nov 2026, Ptc Therapeutics (PTCT) has a market capitalization of $5.48B. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$1.73B

#1217 by revenue

Earnings

$683.0M

#507 by earnings

Shares outstanding

83,544,284

Latest filing cover page

P/E ratio

8.0

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #50GrifolsGRFS$5.85B
  2. #51Belite BioBLTE$5.76B
  3. #52Ptc TherapeuticsPTCT$5.48B
  4. #53VeradermicsMANE$5.38B
  5. #54Cogent BiosciencesCOGT$5.14B

What if Ptc Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$337,986.90

Per share 5,155× higher

Bitcoin $1.53T

$18,287.88

Per share 279× higher

Apple $5.02T

$60,037.41

Per share 916× higher

Or at a round number

$10.0B$20.0B$50.0B$100.0B

Where these numbers come from

Share counts and financials for Ptc Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.